Chern, Chian-Ru
Lauková, Marcela
Schonwald, Antonia
Kudová, Eva
Chodounská, Hana
Chern, Chian-Jiang
Shakarjian, Michael P.
Velíšková, Jana
Velíšek, Libor http://orcid.org/0000-0003-2805-349X
Funding for this research was provided by:
Ústav organické chemie a biochemie Akademie věd České republiky
National Institute of Neurological Disorders and Stroke (R21NS118337-01, R21NS084900, R01NS092786)
Article History
Received: 5 September 2022
Revised: 14 November 2022
Accepted: 15 November 2022
First Online: 23 November 2022
Declarations
:
: LV is a consultant for Angelini Pharma on topics unrelated to this project. Other co-authors have no conflicts to report besides the funding statement.